Stegelmann, Frank http://orcid.org/0000-0003-2157-476X
Wille, Kai
Busen, Hannah http://orcid.org/0000-0003-0607-6033
Fuchs, Christiane http://orcid.org/0000-0003-3565-8315
Schauer, Stefanie
Sadjadian, Parvis
Becker, Tatjana
Kolatzki, Vera
Döhner, Hartmut
Stadler, Rudolf
Döhner, Konstanze
Griesshammer, Martin
,
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB 1243, subproject A17)
Article History
Received: 27 May 2020
Revised: 14 June 2020
Accepted: 17 June 2020
First Online: 3 July 2020
Change Date: 16 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41375-021-01366-3
Compliance with ethical standards
:
: The authors KW, HB, CF, SS, PS, TB, VK, HD, RS declare that there are no competing interests in relation to the work described; FS reports speaker bureau and consultancy for BMS, Incyte, Novartis, and Pfizer, KD for BMS, Celgene, CTI, Novartis, and Roche, MG for AOP Orphan, Celgene, CTI, Novartis, and Shire.